T1-3N0 NSCLC脑转移风险:基于人群的分析

Pub Date : 2020-02-25 DOI:10.2217/lmt-2019-0010
Michael T Milano, James E Bates, Justin Budnik, Haoming Qiu, Sara Hardy, Michael A Cummings, Megan A Baumgart, Ronald J Maggiore, Deborah A Mulford, Kenneth Y Usuki
{"title":"T1-3N0 NSCLC脑转移风险:基于人群的分析","authors":"Michael T Milano,&nbsp;James E Bates,&nbsp;Justin Budnik,&nbsp;Haoming Qiu,&nbsp;Sara Hardy,&nbsp;Michael A Cummings,&nbsp;Megan A Baumgart,&nbsp;Ronald J Maggiore,&nbsp;Deborah A Mulford,&nbsp;Kenneth Y Usuki","doi":"10.2217/lmt-2019-0010","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>Several consensus guidelines recommend against routine brain imaging at diagnosis of T1-3N0 non-small cell lung cancer (NSCLC).</p><p><strong>Methods: </strong>From the Surveillance, Epidemiology and End Results registry, patients with pathologically confirmed T1-3N0 NSCLC were identified. Risks of brain metastases at time of initial diagnosis were analyzed.</p><p><strong>Results: </strong>Patients selected to not undergo primary NSCLC resection had approximately tenfold greater incidence of brain metastases versus those who did. Younger age, adenocarcinoma histology, higher tumor stage and higher histologic grade were all significantly (p < 0.0001) associated with greater likelihood of presenting with brain metastases.</p><p><strong>Conclusion: </strong>Given the morbidity and mortality of brain metastases, routine brain screening after NSCLC diagnosis (particularly adenocarcinoma) may be justifiable, though more refined cost-benefit analyses are warranted.</p>","PeriodicalId":0,"journal":{"name":"","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2217/lmt-2019-0010","citationCount":"6","resultStr":"{\"title\":\"Risk of brain metastases in T1-3N0 NSCLC: a population-based analysis.\",\"authors\":\"Michael T Milano,&nbsp;James E Bates,&nbsp;Justin Budnik,&nbsp;Haoming Qiu,&nbsp;Sara Hardy,&nbsp;Michael A Cummings,&nbsp;Megan A Baumgart,&nbsp;Ronald J Maggiore,&nbsp;Deborah A Mulford,&nbsp;Kenneth Y Usuki\",\"doi\":\"10.2217/lmt-2019-0010\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Aim: </strong>Several consensus guidelines recommend against routine brain imaging at diagnosis of T1-3N0 non-small cell lung cancer (NSCLC).</p><p><strong>Methods: </strong>From the Surveillance, Epidemiology and End Results registry, patients with pathologically confirmed T1-3N0 NSCLC were identified. Risks of brain metastases at time of initial diagnosis were analyzed.</p><p><strong>Results: </strong>Patients selected to not undergo primary NSCLC resection had approximately tenfold greater incidence of brain metastases versus those who did. Younger age, adenocarcinoma histology, higher tumor stage and higher histologic grade were all significantly (p < 0.0001) associated with greater likelihood of presenting with brain metastases.</p><p><strong>Conclusion: </strong>Given the morbidity and mortality of brain metastases, routine brain screening after NSCLC diagnosis (particularly adenocarcinoma) may be justifiable, though more refined cost-benefit analyses are warranted.</p>\",\"PeriodicalId\":0,\"journal\":{\"name\":\"\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0,\"publicationDate\":\"2020-02-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.2217/lmt-2019-0010\",\"citationCount\":\"6\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2217/lmt-2019-0010\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2217/lmt-2019-0010","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 6

摘要

目的:一些一致的指南建议在诊断T1-3N0非小细胞肺癌(NSCLC)时不进行常规脑成像。方法:从监测、流行病学和最终结果登记中,确定病理证实的T1-3N0 NSCLC患者。分析初诊时脑转移的风险。结果:选择不进行原发性非小细胞肺癌切除术的患者的脑转移发生率大约是接受手术的患者的10倍。年龄较小、腺癌组织学、较高的肿瘤分期和较高的组织学分级与出现脑转移的可能性均显著相关(p < 0.0001)。结论:考虑到脑转移的发病率和死亡率,非小细胞肺癌(特别是腺癌)诊断后的常规脑筛查可能是合理的,尽管需要更精确的成本-收益分析。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Risk of brain metastases in T1-3N0 NSCLC: a population-based analysis.

分享
查看原文
Risk of brain metastases in T1-3N0 NSCLC: a population-based analysis.

Aim: Several consensus guidelines recommend against routine brain imaging at diagnosis of T1-3N0 non-small cell lung cancer (NSCLC).

Methods: From the Surveillance, Epidemiology and End Results registry, patients with pathologically confirmed T1-3N0 NSCLC were identified. Risks of brain metastases at time of initial diagnosis were analyzed.

Results: Patients selected to not undergo primary NSCLC resection had approximately tenfold greater incidence of brain metastases versus those who did. Younger age, adenocarcinoma histology, higher tumor stage and higher histologic grade were all significantly (p < 0.0001) associated with greater likelihood of presenting with brain metastases.

Conclusion: Given the morbidity and mortality of brain metastases, routine brain screening after NSCLC diagnosis (particularly adenocarcinoma) may be justifiable, though more refined cost-benefit analyses are warranted.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信